Asthma affects millions of people across the UK and most patients are diagnosed, managed and reviewed in primary care. With demand rising and appointment time limited, clinical teams need fast, reliable tools that support confident decision making. Fractional exhaled nitric oxide FeNO testing offers exactly that, making it one of the most valuable additions to respiratory pathways in GP surgeries and community clinics.
Why primary care needs objective testing
Asthma symptoms can be variable and many patients present without obvious signs on the day of assessment. Relying solely on symptoms or peak flow risks uncertainty and may lead to misdiagnosis or inappropriate treatment.
FeNO testing provides a measurable, objective indicator of whether airway inflammation is present. This helps clinicians move from assumption based decisions to data led assessment.
Rapid, appointment friendly testing
FeNO testing takes only a few minutes and can be completed during routine consultations. Unlike spirometry, it is not effort dependent, which means results are more consistent across age and ability.
FeNO is ideal for:
-
GP urgent appointments regarding breathlessness
-
Community diagnostic hubs
-
PCN phlebotomy or respiratory clinics
-
Chronic disease management pathways
Fast access to results enables confident decision making without requiring follow up simply to gather data.
Improving diagnostic confidence
Many patients with asthma have normal lung function between episodes, making spirometry less useful in early or mild disease. FeNO adds vital clarity when symptoms are ambiguous, especially in children, newly diagnosed patients and individuals with fluctuating patterns.
Using FeNO alongside spirometry and clinical history enables clinicians to make informed choices earlier in line with national clinical guidance, reducing the risk of avoidable deterioration.
Supporting treatment and medication decisions
FeNO testing does more than diagnose asthma. It plays a key role in optimising therapy throughout long term care.
FeNO helps clinicians decide:
-
When to start inhaled corticosteroids
-
Whether poor control is linked to inflammation
-
When a treatment step up is necessary
-
Whether a step down is safe
-
How to approach non adherence
This improves clinical outcomes and supports responsible prescribing, particularly within pressured NHS budgets.
Empowering primary care clinicians
The shift of respiratory care from hospitals to community settings means GPs, ANPs, practice nurses and healthcare assistants are increasingly involved in managing asthma.
FeNO testing:
-
Reduces reliance on hospital referrals
-
Provides reassurance when diagnosis is uncertain
-
Standardises asthma care across practices within a PCN
-
Strengthens multi disciplinary decision making
By placing a proven diagnostic tool at the front line, FeNO allows primary care teams to take ownership of respiratory management with confidence.
Better outcomes for patients
Patients benefit most when asthma is identified early and treated appropriately. FeNO supports this by identifying inflammation before symptoms escalate, reducing the likelihood of urgent care attendance, steroid bursts or emergency admissions.
For patients, FeNO testing:
-
Validates symptoms
-
Supports personalised care
-
Improves adherence
-
Reduces uncertainty and anxiety
-
Strengthens shared decision making
A future proof investment for GP practices
As ICS use becomes more targeted, as guidelines evolve and as NHS capacity pressures increase, FeNO testing is aligning closely with national priorities.
It offers:
-
Simplicity
-
Repeatability
-
Patient friendliness
-
Consistency across services
This makes FeNO a tool that not only improves care but also enhances efficiency for practices, PCNs and integrated respiratory clinics.
In summary
FeNO testing is transforming asthma care across the UK. By providing rapid insight into airway inflammation, it strengthens diagnosis, guides treatment and supports safer long term management. Bringing FeNO into GP surgeries and community clinics ensures patients receive accurate, consistent and timely asthma care close to home.
Comments are closed.